PPP1R26P2

Across TCGA pan-cancer cohorts, PPP1R26P2 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated PPP1R26P2 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher PPP1R26P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated PPP1R26P2 expression acts as an unfavorable survival marker.

UCS, LIHC, and THCA are the cancer types where PPP1R26P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	All	0.116	0.699	<.001	144	view →
LIHC	OS	Tertile	II,III,IV	0.089	0.716	<.001	54	view →
THCA	DFS	Tertile	IV	0.027	0.937	<.001	42	view →
LGG	OS	Tertile	All	0.200	0.529	.002	27	view →
ACC	DFS	Tertile	All	0.066	0.623	.006	18	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
PCPG	DFS	Tertile	All	0.552	0.902	.029	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

PPP1R26P2–UCS (OS)

Open the UCS breakdown →